{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:36:04Z","timestamp":1769150164131,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10067-023-06683-9","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T20:31:43Z","timestamp":1690230703000},"page":"3213-3223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Retrospective analysis and preliminary laboratory validation of treatment efficacy and blood lipid levels in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"42","author":[{"given":"Yuchun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4630-976X","authenticated-orcid":false,"given":"Genhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"6683_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB (2017) Immunopathogenesis of rheumatoid arthritis. Immunity 46:183\u2013196","journal-title":"Immunity"},{"key":"6683_CR2","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201901010","volume":"170","author":"JA Sparks","year":"2019","unstructured":"Sparks JA (2019) Rheumatoid arthritis. Ann Intern Med 170:ITC1\u2013ITC6","journal-title":"Ann Intern Med"},{"key":"6683_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrrheum.2010.105","volume":"6","author":"GD Summers","year":"2010","unstructured":"Summers GD, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD (2010) Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol 6:445\u2013451","journal-title":"Nat Rev Rheumatol"},{"key":"6683_CR4","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A (2021) Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev 20:102776","journal-title":"Autoimmun Rev"},{"key":"6683_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/art.41095","volume":"72","author":"JT Giles","year":"2020","unstructured":"Giles JT, Sattar N, Gabriel S, Ridker PM, Gay S, Warne C, Musselman D, Brockwell L, Shittu E, Klearman M, Fleming TR (2020) Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial. Arthritis Rheumatol 72:31\u201340","journal-title":"Arthritis Rheumatol"},{"key":"6683_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/ehjcvp\/pvz033","volume":"6","author":"I Hollan","year":"2020","unstructured":"Hollan I, Ronda N, Dessein P, Agewall S, Karpouzas G, Tamargo J, Niessner A, Savarese G, Rosano G, Kaski JC, Wassmann S, Meroni PL (2020) Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. Eur Heart J Cardiovasc Pharmacother 6:104\u2013114","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"6683_CR7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/art.38974","volume":"67","author":"C Charles-Schoeman","year":"2015","unstructured":"Charles-Schoeman C, Fleischmann R, Davignon J, Schwartz H, Turner SM, Beysen C, Milad M, Hellerstein MK, Luo Z, Kaplan IV, Riese R, Zuckerman A, McInnes IB (2015) Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib. Arthritis Rheumatol 67:616\u2013625","journal-title":"Arthritis Rheumatol"},{"key":"6683_CR8","first-page":"803","volume":"8","author":"FS Pierini","year":"2021","unstructured":"Pierini FS, Botta E, Soriano ER, Martin M, Boero L, Merono T, Saez MS, Lozano Chiappe E, Cerda O, Citera G, Gandino I, Rosa J, Sorroche P, Kontush A, Brites F (2021) Effect of tocilizumab on LDL and HDL characteristics in patients with rheumatoid arthritis. An Observational Study Rheumatol Ther 8:803\u2013815","journal-title":"An Observational Study Rheumatol Ther"},{"key":"6683_CR9","first-page":"1746","volume":"31","author":"WH Yoo","year":"2004","unstructured":"Yoo WH (2004) Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles. J Rheumatol 31:1746\u20131753","journal-title":"J Rheumatol"},{"key":"6683_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S2215-0366(18)30255-4","volume":"6","author":"L Nerurkar","year":"2019","unstructured":"Nerurkar L, Siebert S, McInnes IB, Cavanagh J (2019) Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry 6:164\u2013173","journal-title":"Lancet Psychiatry"},{"key":"6683_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","volume":"17","author":"MH Buch","year":"2021","unstructured":"Buch MH, Eyre S, McGonagle D (2021) Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis. Nat Rev Rheumatol 17:17\u201333","journal-title":"Nat Rev Rheumatol"},{"key":"6683_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/art.38894","volume":"67","author":"A Souto","year":"2015","unstructured":"Souto A, Salgado E, Maneiro JR, Mera A, Carmona L, Gomez-Reino JJ (2015) Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysis. Arthritis Rheumatol 67:117\u2013127","journal-title":"Arthritis Rheumatol"},{"key":"6683_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s11926-012-0269-z","volume":"14","author":"M Amezaga Urruela","year":"2012","unstructured":"Amezaga Urruela M, Suarez-Almazor ME (2012) Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies. Curr Rheumatol Rep 14:428\u2013437","journal-title":"Curr Rheumatol Rep"},{"key":"6683_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrrheum.2013.91","volume":"9","author":"J Robertson","year":"2013","unstructured":"Robertson J, Peters MJ, McInnes IB, Sattar N (2013) Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol 9:513\u2013523","journal-title":"Nat Rev Rheumatol"},{"key":"6683_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11882-014-0497-6","volume":"15","author":"A Bag-Ozbek","year":"2015","unstructured":"Bag-Ozbek A, Giles JT (2015) Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship? Curr Allergy Asthma Rep 15:497","journal-title":"Curr Allergy Asthma Rep"},{"key":"6683_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.curtheres.2018.07.001","volume":"89","author":"U Bergstrom","year":"2018","unstructured":"Bergstrom U, Jovinge S, Persson J, Jacobsson LTH, Turesson C (2018) Effects of treatment with adalimumab on blood lipid levels and atherosclerosis in patients with rheumatoid arthritis. Curr Ther Res Clin Exp 89:1\u20136","journal-title":"Curr Ther Res Clin Exp"},{"key":"6683_CR17","doi-asserted-by":"crossref","unstructured":"Hoffman E, Rahat MA, Feld J, Elias M, Rosner I, Kaly L, Lavie I, Gazitt T, Zisman D (2019) Effects of tocilizumab, an anti-interleukin-6 receptor antibody, on serum lipid and adipokine levels in patients with rheumatoid arthritis. Int J Mol Sci 20:4633\u20134644","DOI":"10.3390\/ijms20184633"},{"key":"6683_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.semarthrit.2008.01.015","volume":"38","author":"G Steiner","year":"2009","unstructured":"Steiner G, Urowitz MB (2009) Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 38:372\u2013381","journal-title":"Semin Arthritis Rheum"},{"key":"6683_CR19","first-page":"vi5","volume":"51 Suppl 6","author":"J Kay","year":"2012","unstructured":"Kay J, Upchurch KS (2012) ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford) 51 Suppl 6:vi5-9","journal-title":"Rheumatology (Oxford)"},{"key":"6683_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/ard.2006.051672","volume":"66","author":"VP van Halm","year":"2007","unstructured":"van Halm VP, Nielen MM, Nurmohamed MT, van Schaardenburg D, Reesink HW, Voskuyl AE, Twisk JW, van de Stadt RJ, de Koning MH, Habibuw MR, van der Horst-Bruinsma IE, Dijkmans BA (2007) Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 66:184\u2013188","journal-title":"Ann Rheum Dis"},{"key":"6683_CR21","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","volume":"358","author":"DM Lee","year":"2001","unstructured":"Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903\u2013911","journal-title":"Lancet"},{"key":"6683_CR22","first-page":"191","volume":"91","author":"S Iannello","year":"2000","unstructured":"Iannello S, Camuto M, Cavaleri A, Fagone S, Belfiore F (2000) Psoriasis complicated with severe mutilating psoriatic osteoarthropathy. Clinical case and review of the literature. Minerva Med 91:191\u2013226","journal-title":"Minerva Med"},{"key":"6683_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/rheumatology\/keh484","volume":"44","author":"BF Leeb","year":"2005","unstructured":"Leeb BF, Andel I, Leder S, Leeb BA, Rintelen B (2005) The patient\u2019s perspective and rheumatoid arthritis disease activity indexes. Rheumatology (Oxford) 44:360\u2013365","journal-title":"Rheumatology (Oxford)"},{"key":"6683_CR24","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1093\/rheumatology\/keaa649","volume":"60","author":"I Liebold","year":"2021","unstructured":"Liebold I, Grutzkau A, Gockeritz A, Gerl V, Lindquist R, Feist E, Zanker M, Haupl T, Poddubnyy D, Zernicke J, Smiljanovic B, Alexander T, Burmester GR, Gay S, Stuhlmuller B (2021) Peripheral blood mononuclear cells are hypomethylated in active rheumatoid arthritis and methylation correlates with disease activity. Rheumatology (Oxford) 60:1984\u20131995","journal-title":"Rheumatology (Oxford)"},{"key":"6683_CR25","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023\u20132038","journal-title":"Lancet"},{"key":"6683_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.biochi.2019.11.016","volume":"169","author":"E Jarc","year":"2020","unstructured":"Jarc E, Petan T (2020) A twist of FATe: lipid droplets and inflammatory lipid mediators. Biochimie 169:69\u201387","journal-title":"Biochimie"},{"key":"6683_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/imr.12891","volume":"297","author":"PK Anand","year":"2020","unstructured":"Anand PK (2020) Lipids, inflammasomes, metabolism, and disease. Immunol Rev 297:108\u2013122","journal-title":"Immunol Rev"},{"key":"6683_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.berh.2016.02.003","volume":"29","author":"H Brouwers","year":"2015","unstructured":"Brouwers H, von Hegedus J, Toes R, Kloppenburg M, Ioan-Facsinay A (2015) Lipid mediators of inflammation in rheumatoid arthritis and osteoarthritis. Best Pract Res Clin Rheumatol 29:741\u2013755","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"6683_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.nutr.25.050304.092610","volume":"26","author":"K Fritsche","year":"2006","unstructured":"Fritsche K (2006) Fatty acids as modulators of the immune response. Annu Rev Nutr 26:45\u201373","journal-title":"Annu Rev Nutr"},{"key":"6683_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1741-7015-12-48","volume":"12","author":"N Damjanov","year":"2014","unstructured":"Damjanov N, Nurmohamed MT, Szekanecz Z (2014) Biologics, cardiovascular effects and cancer. BMC Med 12:48","journal-title":"BMC Med"},{"key":"6683_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/BOR.0000000000000017","volume":"26","author":"MK Demoruelle","year":"2014","unstructured":"Demoruelle MK, Deane KD, Holers VM (2014) When and where does inflammation begin in rheumatoid arthritis? Curr Opin Rheumatol 26:64\u201371","journal-title":"Curr Opin Rheumatol"},{"key":"6683_CR32","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0140-6736(77)92666-6","volume":"2","author":"HC Thomas","year":"1977","unstructured":"Thomas HC, Potter BJ, Sherlock S (1977) Is primary biliary cirrhosis an immune complex disease? Lancet 2:1261\u20131263","journal-title":"Lancet"},{"key":"6683_CR33","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0140-6736(79)91947-0","volume":"1","author":"BD Williams","year":"1979","unstructured":"Williams BD, Pussell BA, Lockwood CM, Cotton C (1979) Defective reticuloendothelial system function in rheumatoid arthritis. Lancet 1:1311\u20131314","journal-title":"Lancet"},{"key":"6683_CR34","doi-asserted-by":"publisher","first-page":"R1189","DOI":"10.1186\/ar1804","volume":"7","author":"M Rossol","year":"2005","unstructured":"Rossol M, Kaltenhauser S, Scholz R, Hantzschel H, Hauschildt S, Wagner U (2005) The contact-mediated response of peripheral-blood monocytes to preactivated T cells is suppressed by serum factors in rheumatoid arthritis. Arthritis Res Ther 7:R1189\u2013R1199","journal-title":"Arthritis Res Ther"},{"key":"6683_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.vph.2016.01.006","volume":"81","author":"GW Naerr","year":"2016","unstructured":"Naerr GW, Rein P, Saely CH, Drexel H (2016) Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis. Vascul Pharmacol 81:22\u201330","journal-title":"Vascul Pharmacol"},{"key":"6683_CR36","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2174\/0929867321666140303153430","volume":"21","author":"D Kardassis","year":"2014","unstructured":"Kardassis D, Mosialou I, Kanaki M, Tiniakou I, Thymiakou E (2014) Metabolism of HDL and its regulation. Curr Med Chem 21:2864\u20132880","journal-title":"Curr Med Chem"},{"key":"6683_CR37","doi-asserted-by":"crossref","unstructured":"Behl T, Kaur I, Sehgal A, Zengin G, Brisc C, Brisc MC, Munteanu MA, Nistor-Cseppento DC, Bungau S (2020) The lipid paradox as a metabolic checkpoint and its therapeutic significance in ameliorating the associated cardiovascular risks in rheumatoid arthritis patients. Int J Mol Sci 21:9505\u20139532","DOI":"10.3390\/ijms21249505"},{"key":"6683_CR38","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1007\/s11033-021-06553-0","volume":"48","author":"X Su","year":"2021","unstructured":"Su X, Zhang G, Cheng Y, Wang B (2021) New insights into the emerging effects of inflammatory response on HDL particles structure and function. Mol Biol Rep 48:5723\u20135733","journal-title":"Mol Biol Rep"},{"key":"6683_CR39","doi-asserted-by":"crossref","unstructured":"Ahmed S, Jacob B, Carsons SE, De Leon J, Reiss AB (2021) Treatment of cardiovascular disease in rheumatoid arthritis: a complex challenge with increased atherosclerotic risk. Pharmaceuticals (Basel) 15:11","DOI":"10.3390\/ph15010011"},{"key":"6683_CR40","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/CIRCRESAHA.120.317362","volume":"127","author":"JHC Yiu","year":"2020","unstructured":"Yiu JHC, Chan KS, Cheung J, Li J, Liu Y, Wang Y, Fung WWL, Cai J, Cheung SWM, Dorweiler B, Wan EYF, Tso P, Xu A, Woo CW (2020) Gut microbiota-associated activation of TLR5 induces apolipoprotein A1 production in the liver. Circ Res 127:1236\u20131252","journal-title":"Circ Res"},{"key":"6683_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fphar.2015.00187","volume":"6","author":"KY Chyu","year":"2015","unstructured":"Chyu KY, Shah PK (2015) HDL\/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis. Front Pharmacol 6:187","journal-title":"Front Pharmacol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06683-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06683-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06683-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T07:16:54Z","timestamp":1699687014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06683-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["6683"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06683-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"3 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our study was approved by the Ethics Committee of the Affiliated Drum Tower Hospital of Nanjing University\u00a0Medical School (No. 2021\u2013544-01).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}